Leisha Emens

Leisha Emens

Company: University of Pittsburgh Department of Medicine

Job title: Professor of Medicine


Immunotherapy for Triple Negative Breast Cancer 2:00 pm

• Triple negative breast cancer may be immune-driven • The combination of PD-1/PD-L1 inhibitors and chemotherapy is a new standard of care for metastatic triple negative breast cancer • Adding PD-1/PD-L1 inhibitors to standard neoadjuvant chemotherapy improves pathologic responses in early triple negative breast cancerRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.